June 12 (Reuters) - The U.S. Food and Drug Administration
has approved a drug to treat infants and children with HIV, with
the drug having been developed by drugmaker GlaxoSmithKline's
HIV drugs division ViiV Healthcare, the FDA and the GSK
unit said.
The FDA said on Friday it was granting Viiv the approval of
Tivicay and Tivicay PD tablets "for suspension to treat HIV-1
infection in pediatric patients at least four weeks old and
weighing at least 3 kgs in combination with other antiretroviral
treatments".
The drug is currently under review by the European Medicines
Agency, ViiV, in which Pfizer and Shionogi have
small stakes, said in a separate statement.
(Reporting by Kanishka Singh in Bengaluru
Editing by Chizu Nomiyama)